H1N1 Vaccines Market Research Report by Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global H1N1 Vaccines Market is expected to grow from USD 4,020.51 Million in 2020 to USD 17,688.12 Million by the end of 2025.
2. The Global H1N1 Vaccines Market is expected to grow from EUR 3,525.26 Million in 2020 to EUR 15,509.28 Million by the end of 2025.
3. The Global H1N1 Vaccines Market is expected to grow from GBP 3,133.97 Million in 2020 to GBP 13,787.78 Million by the end of 2025.
4. The Global H1N1 Vaccines Market is expected to grow from JPY 429,091.30 Million in 2020 to JPY 1,887,771.13 Million by the end of 2025.
5. The Global H1N1 Vaccines Market is expected to grow from AUD 5,838.32 Million in 2020 to AUD 25,685.50 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the H1N1 Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Route of Administration, the H1N1 Vaccines Market studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.
Based on Geography, the H1N1 Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global H1N1 Vaccines Market including Abbott, Baxter International, Cipla, GSK, Hualan Biological Engineering, Merck, Mitsubishi Tanabe Pharma, Pfizer, Sanofi, and Sinovac Biotech.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the H1N1 Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global H1N1 Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global H1N1 Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global H1N1 Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global H1N1 Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global H1N1 Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global H1N1 Vaccines Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global H1N1 Vaccines Market is expected to grow from USD 4,020.51 Million in 2020 to USD 17,688.12 Million by the end of 2025.
2. The Global H1N1 Vaccines Market is expected to grow from EUR 3,525.26 Million in 2020 to EUR 15,509.28 Million by the end of 2025.
3. The Global H1N1 Vaccines Market is expected to grow from GBP 3,133.97 Million in 2020 to GBP 13,787.78 Million by the end of 2025.
4. The Global H1N1 Vaccines Market is expected to grow from JPY 429,091.30 Million in 2020 to JPY 1,887,771.13 Million by the end of 2025.
5. The Global H1N1 Vaccines Market is expected to grow from AUD 5,838.32 Million in 2020 to AUD 25,685.50 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the H1N1 Vaccines to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Route of Administration, the H1N1 Vaccines Market studied across Intradermal Vaccines, Intramuscular Vaccines, and Intranasal Vaccines.
Based on Geography, the H1N1 Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global H1N1 Vaccines Market including Abbott, Baxter International, Cipla, GSK, Hualan Biological Engineering, Merck, Mitsubishi Tanabe Pharma, Pfizer, Sanofi, and Sinovac Biotech.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the H1N1 Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global H1N1 Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global H1N1 Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global H1N1 Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global H1N1 Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global H1N1 Vaccines Market?
6. What are the modes and strategic moves considered suitable for entering the Global H1N1 Vaccines Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administration Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL H1N1 VACCINES MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Intradermal Vaccines
6.3. Intramuscular Vaccines
6.4. Intranasal Vaccines
7. AMERICAS H1N1 VACCINES MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC H1N1 VACCINES MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Abbott
11.2. Baxter International
11.3. Cipla
11.4. GSK
11.5. Hualan Biological Engineering
11.6. Merck
11.7. Mitsubishi Tanabe Pharma
11.8. Pfizer
11.9. Sanofi
11.10. Sinovac Biotech
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Route of Administration Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL H1N1 VACCINES MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Intradermal Vaccines
6.3. Intramuscular Vaccines
6.4. Intranasal Vaccines
7. AMERICAS H1N1 VACCINES MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC H1N1 VACCINES MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Abbott
11.2. Baxter International
11.3. Cipla
11.4. GSK
11.5. Hualan Biological Engineering
11.6. Merck
11.7. Mitsubishi Tanabe Pharma
11.8. Pfizer
11.9. Sanofi
11.10. Sinovac Biotech
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL H1N1 VACCINES MARKET: SCORES
TABLE 40. GLOBAL H1N1 VACCINES MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL H1N1 VACCINES MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL H1N1 VACCINES MARKET: RANKING
TABLE 43. GLOBAL H1N1 VACCINES MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL H1N1 VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL H1N1 VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL H1N1 VACCINES MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL H1N1 VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL H1N1 VACCINES MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. AMERICAS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. ARGENTINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. BRAZIL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. CANADA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. MEXICO H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. UNITED STATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CHINA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. INDIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. INDONESIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. JAPAN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MALAYSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. THAILAND H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. FRANCE H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. GERMANY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ITALY H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. QATAR H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. RUSSIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. SPAIN H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. GLOBAL H1N1 VACCINES MARKET: SCORES
TABLE 40. GLOBAL H1N1 VACCINES MARKET: BUSINESS STRATEGY
TABLE 41. GLOBAL H1N1 VACCINES MARKET: PRODUCT SATISFACTION
TABLE 42. GLOBAL H1N1 VACCINES MARKET: RANKING
TABLE 43. GLOBAL H1N1 VACCINES MARKET: MERGER & ACQUISITION
TABLE 44. GLOBAL H1N1 VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 45. GLOBAL H1N1 VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 46. GLOBAL H1N1 VACCINES MARKET: INVESTMENT & FUNDING
TABLE 47. GLOBAL H1N1 VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 48. GLOBAL H1N1 VACCINES MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL H1N1 VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL H1N1 VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL H1N1 VACCINES MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL H1N1 VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL H1N1 VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL H1N1 VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL H1N1 VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL H1N1 VACCINES MARKET, BY TYPE
FIGURE 1. GLOBAL H1N1 VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL H1N1 VACCINES MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL H1N1 VACCINES MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL H1N1 VACCINES MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL H1N1 VACCINES MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL H1N1 VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 13. GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL H1N1 VACCINES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 15. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRADERMAL VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRAMUSCULAR VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL H1N1 VACCINES MARKET SIZE, BY INTRANASAL VACCINES, 2020 VS 2025 (USD MILLION)
FIGURE 18. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 19. AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 21. ARGENTINA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 22. BRAZIL H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 23. CANADA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 24. MEXICO H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 25. UNITED STATES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 26. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 27. ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 29. AUSTRALIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. CHINA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. INDIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. INDONESIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. JAPAN H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. MALAYSIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. PHILIPPINES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. SOUTH KOREA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. THAILAND H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 40. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 41. FRANCE H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. GERMANY H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. ITALY H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. NETHERLANDS H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. QATAR H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. RUSSIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. SAUDI ARABIA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. SOUTH AFRICA H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. SPAIN H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. UNITED ARAB EMIRATES H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. UNITED KINGDOM H1N1 VACCINES MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. GLOBAL H1N1 VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL H1N1 VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 54. GLOBAL H1N1 VACCINES MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 55. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL H1N1 VACCINES MARKET, BY TYPE
